Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
Authors
Kai Antweiler (ORCID: https://orcid.org/0000-0003-3849-044X)
Michael Ghadimi (ORCID: https://orcid.org/0000-0001-8208-1526)
Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
Kai Antweiler, Michael Ghadimi, Uwe Pelzer, Ralph Telgmann et al.
Citations
9 citations
Journal
BMC Cancer
Topics
Pancreatic and Hepatic Oncology Research
Field-Weighted Citation Impact (FWCI)
9.41
article
Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
Kai Antweiler, Michael Ghadimi, Uwe Pelzer, Ralph Telgmann, Bas A. Uijterwijk, Rickmer Braren, Marc G. Besselink, Hanneke Wilmink, Olav Dajani, Ute Koenig, Knut Jørgen Labori, Pauli Puolakkainen, Peter Jo, Hanna Seppänen, Alexander Köenig, Tim Friede, Jens Thomas Siveke, Arno Nordin, Svein Olav Bratlie, Marie Crede, Mia Johansson, Sven T. Liffers
article en
9 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC CancerVol. 25(1)
Institutions
Oslo University Hospital (NO), University of Helsinki (FI), Helsinki University Hospital (FI), Sahlgrenska University Hospital (SE), TUM Klinikum (DE), Humboldt-Universität zu Berlin (DE), Universitätsmedizin Göttingen (DE), Essen University Hospital (DE), Amsterdam University Medical Centers (NL), Technical University of Munich (DE), University of Göttingen (DE), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE), University of Amsterdam (NL)